Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Review ArticleREVIEW ARTICLE
Open Access

Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 2—Surveillance for Treatment Complications and Disease Progression

C. McNamara, G. Sugrue, B. Murray and P.J. MacMahon
American Journal of Neuroradiology April 2017, DOI: https://doi.org/10.3174/ajnr.A5148
C. McNamara
From the Departments of Radiology (C.M., G.S., P.J.M.) and Neurology (B.M.), Mater Misericordiae University Hospital, Dublin, Ireland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. McNamara
G. Sugrue
From the Departments of Radiology (C.M., G.S., P.J.M.) and Neurology (B.M.), Mater Misericordiae University Hospital, Dublin, Ireland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for G. Sugrue
B. Murray
From the Departments of Radiology (C.M., G.S., P.J.M.) and Neurology (B.M.), Mater Misericordiae University Hospital, Dublin, Ireland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for B. Murray
P.J. MacMahon
From the Departments of Radiology (C.M., G.S., P.J.M.) and Neurology (B.M.), Mater Misericordiae University Hospital, Dublin, Ireland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for P.J. MacMahon
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

SUMMARY: An understanding of the new generation of MS drugs in conjunction with the key role MR imaging plays in the detection of disease progression, opportunistic infections, and drug-related adverse effects is of vital importance to the neuroradiologist. Part 1 of this review outlined the current treatment options available for MS and examined the mechanisms of action of the various medications. It also covered specific complications associated with each form of therapy. Part 2, in turn deals with the subject of pharmacovigilance and the optimal frequency of MRI monitoring for each individual patient, depending on his or her unique risk profile. Special attention is given to the diagnosing of progressive multifocal leukoencephalopathy in patients treated with natalizumab as this is a key area in which neuroradiologists can contribute to improved patient outcomes. This article also outlines the aims of treatment and reviews the possibility of “no evidence of disease activity” becoming a treatment goal with the availability of more effective therapies. Potential future areas and technologies including image subtraction, brain volume measurement and advanced imaging techniques such as double inversion recovery are also reviewed. It is anticipated that such advancements in this rapidly developing field will improve the accuracy of monitoring an individual patient's response to treatment.

Abbreviations

BV
brain volume
DIR
double inversion recovery
DMT
disease-modifying therapy
IRIS
immune reconstitution inflammatory syndrome
JC virus
John Cunningham virus
MTR
magnetization transfer ratio
NEDA
no evidence of disease activity
NTZ
natalizumab
NTZ PML
natalizumab-associated PML
PML
progressive multifocal leukoencephalopathy
PML IRIS
PML-associated IRIS
PSIR
phase-sensitive inversion recovery
  • © 2017 American Society of Neuroradiology

Indicates open access to non-subscribers at www.ajnr.org

Next
Back to top
Advertisement
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 2—Surveillance for Treatment Complications and Disease Progression
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 2—Surveillance for Treatment Complications and Disease Progression
C. McNamara, G. Sugrue, B. Murray, P.J. MacMahon
American Journal of Neuroradiology Apr 2017, DOI: 10.3174/ajnr.A5148

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 2—Surveillance for Treatment Complications and Disease Progression
C. McNamara, G. Sugrue, B. Murray, P.J. MacMahon
American Journal of Neuroradiology Apr 2017, DOI: 10.3174/ajnr.A5148
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref (9)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Depletion of PD-1-positive cells ameliorates autoimmune disease
    Peng Zhao, Peng Wang, Shuyun Dong, Zemin Zhou, Yanguang Cao, Hideo Yagita, Xiao He, Song Guo Zheng, Simon J. Fisher, Robert S. Fujinami, Mingnan Chen
    Nature Biomedical Engineering 2019 3 4
  • The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis
    Géraldine Leva, Christian Klein, Jérémie Benyounes, François Hallé, Frédéric Bihel, Nicolas Collongues, Jérôme De Seze, Ayikoe-Guy Mensah-Nyagan, Christine Patte-Mensah
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017 1863 12
  • A PD-1-specific toxin suppresses autoimmunity
    Zhirui Wang, Christene A. Huang
    Nature Biomedical Engineering 2019 3 4
  • Neuroimaging for the Neurologist
    Nandor K. Pinter, Joseph V. Fritz
    Neurologic Clinics 2020 38 1
  • Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes
    Jia-Tong Ding, Kang-Ping Yang, Kong-Lan Lin, Yu-Ke Cao, Fang Zou
    Frontiers in Endocrinology 2023 13
  • Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis
    Chiara Tremolanti, Chiara Cavallini, Laurence Meyer, Christian Klein, Eleonora Da Pozzo, Barbara Costa, Lorenzo Germelli, Sabrina Taliani, Christine Patte-Mensah, Ayikoé-Guy Mensah-Nyagan
    Molecular Neurobiology 2022 59 3
  • Radiopaedia.org
    Derek Smith, Frank Gaillard
    2008
  • The ethical matrix as a method for involving people living with disease and the wider public (PPI) in near-term artificial intelligence research
    B.S. Kelly, A. Kirwan, M.S. Quinn, A.M. Kelly, P. Mathur, A. Lawlor, R.P. Killeen
    Radiography 2023 29
  • The effect of combining PD-1 agonist and low-dose Interleukin-2 on treating systemic lupus erythematosus
    Bing Wang, Can Chen, Xia Liu, Shuang Zhou, Ting Xu, Min Wu
    Frontiers in Immunology 2023 14

More in this TOC Section

REVIEW ARTICLE

  • Advances in Acute Ischemic Stroke Treatment: Current Status and Future Directions
  • Comprehensive Update and Review of Clinical and Imaging Features of SMART Syndrome
  • Head CT: Toward Making Full Use of the Information the X-Rays Give
Show more REVIEW ARTICLE

ADULT BRAIN

  • Evaluation of Motion-Corrected Multishot Echo-Planar Imaging as an Alternative to Gradient Recalled-Echo for Blood-Sensitive Imaging
  • Automated Segmentation of Intracranial Thrombus on NCCT and CTA in Patients with Acute Ischemic Stroke Using a Coarse-to-Fine Deep Learning Model
  • NCCT Markers of Intracerebral Hemorrhage Expansion Using Revised Criteria: An External Validation of Their Predictive Accuracy
Show more ADULT BRAIN

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2022 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2023 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire